Regulations.gov document
Reference 3 GDUFA Reauthorization Performance Goals & Program Enhancements Fiscal Years…
Supporting & Related Material · FDA-2021-P-0550 · posted Jun 16, 2021
Key facts
| Document ID | FDA-2021-P-0550-0006 |
|---|---|
| Title | Reference 3 GDUFA Reauthorization Performance Goals & Program Enhancements Fiscal Years 2018-2022, at 25. re: Citizen Petition from Baker Hostetler on behalf of Bausch Health Companies, Inc_ REDACTED |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2021-P-0550 |
| Posted | Jun 16, 2021 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: